AzTrials
AzTrials

Abstract ThinkingNCT01100281

Prefrontal Cortex and Abstract Thinking

An observational study of Abstract Thinking and Concept Formation, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The capacity of concept formation is not well understood, even if a link is supposed with the functioning of the frontal lobes. Our aim is to better understand the cognitive mechanisms underlying this function and to try to correlate the performance with atrophy of the frontal lobe in neurodegenerative diseases… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Abstract Thinking, Concept Formation
What is being tested?
Neuropsychological examination and MRI
How many people
69 participants
Where
1 siteFrance
Study dates
Apr 2010to Apr 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: 3 groups including : PSP, FTD, AD

Who may be able to join

  • informed consent signed
  • MMSE> 20
  • No contra indication to MRI

Who cannot join

  • MMSE<20

Trial locations and contacts

1 site in 1 country.

France1 site
  • Inserm U 975

    Paris, 75013

Other trials in France

About this study

Official title: Neuropsychological and Anatomical Study of Concept Formation in Frontal Patients

The capacity of concept formation is not well understood, even if a link is supposed with the functioning of the frontal lobes.

Our aim is to better understand the cognitive mechanisms underlying this function and to try to correlate the performance with atrophy of the frontal lobe in neurodegenerative diseases involving this region (frontotemporal lobar degeneration and progressive supranuclear palsy).

Being tested
Neuropsychological examination, MRI
Keywords
prefrontal cortex

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuropsychological examinationBehavioural

    Examination including especially concept formation

  • MRIOther

    MRI performed in T1-weighted three dimensional sequence

Study groups in NCT01100281
Study groupRoleWhat they receive
PSP (Progressive supranuclear palsy)Not described
Receives: Behavioral: Neuropsychological examination; Other: MRI
FTD (Frontotemporal lobar degenerative)Not described
Receives: Behavioral: Neuropsychological examination; Other: MRI
Alzheimer's diseaseNot described
Receives: Behavioral: Neuropsychological examination; Other: MRI

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2010 (estimated)
  2. Study startApr 2010
  3. Study completionApr 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
69 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01100281
Sponsor's protocol ID
C09-29
Status last verified
Dec 2011
First submitted
7 Apr 2010
Last updated
9 Dec 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Abstract Thinking and Concept Formation, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2011.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in